SCHEMBL30296041

SCHEMBL30296041

C[C@H]1OCC2(CCN(C(=O)O)CC2)[C@H]1N[S@+]([O-])C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16914417 1.00 — —
SCHEMBL22798668 1.00 — —
SCHEMBL20571856 1.00 — —
SCHEMBL22799054 1.00 — —
SCHEMBL20571857 1.00 — —
SCHEMBL18330203 0.86 USP2 (0.37) —
SCHEMBL31184432 0.86 USP2 (0.37) —
SCHEMBL22084450 0.86 USP2 (0.37) —
SCHEMBL20571735 0.86 USP2 (0.37) —
SCHEMBL16925343 0.86 USP2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478131-A 2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-07-25 — — CN disclosed
CN-116478132-A 2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-07-25 — — CN disclosed
CN-109983001-B 2, 5-disubstituted 3-methylpyrazines and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-04-04 — — CN disclosed
Send feedback